These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8356457)

  • 21. Platelet-leukocyte-cross-talk in diabetes mellitus.
    Tschoepe D; Rauch U; Schwippert B
    Horm Metab Res; 1997 Dec; 29(12):631-5. PubMed ID: 9497901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albuminuria--a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus.
    Jensen T
    Dan Med Bull; 1991 Apr; 38(2):134-44. PubMed ID: 2060321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between lipoprotein(a) and the complications of diabetes mellitus.
    Koschinsky ML; Marcovina SM
    Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration of platelet glucose transport system in atherosclerosis.
    Yardimci T; Ulutin ON
    Wien Klin Wochenschr; 1986 Apr; 98(7):221-4. PubMed ID: 3010581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus.
    Belch JJ; Mackay IR; Hill A; Jennings P; McCollum P
    Int Angiol; 1995 Dec; 14(4):385-8. PubMed ID: 8708432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The late complications of diabetes mellitus.
    Squadrito G; Cucinotta D
    Ann Ital Med Int; 1991; 6(1 Pt 2):126-36. PubMed ID: 1742148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherogenesis and atherothrombosis--focus on diabetes mellitus.
    Stratmann B; Tschoepe D
    Best Pract Res Clin Endocrinol Metab; 2009 Jun; 23(3):291-303. PubMed ID: 19520304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients.
    Elalamy I; Chakroun T; Gerotziafas GT; Petropoulou A; Robert F; Karroum A; Elgrably F; Samama MM; Hatmi M
    Thromb Res; 2008; 121(6):843-8. PubMed ID: 17825880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of mobile receptors on surface- and suspension-activated platelets.
    Escolar G; Clemetson K; White JG
    J Lab Clin Med; 1994 Apr; 123(4):536-46. PubMed ID: 8145002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
    Tomer A
    J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
    Mikhail N; Fukuda N; Tremblay J; Hamet P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S64-74. PubMed ID: 7508064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet abnormalities in diabetes mellitus.
    Glassman AB
    Ann Clin Lab Sci; 1993; 23(1):47-50. PubMed ID: 8431000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
    Fuster V; Stein B; Ambrose JA; Badimon L; Badimon JJ; Chesebro JH
    Circulation; 1990 Sep; 82(3 Suppl):II47-59. PubMed ID: 2203564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The contact phase of blood coagulation in diabetes mellitus and in patients with vasculopathy.
    Christe M; Gattlen P; Fritschi J; Lämmle B; Berger W; Marbet GA; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):221-3. PubMed ID: 6085193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus.
    Watala C
    Curr Pharm Des; 2005; 11(18):2331-65. PubMed ID: 16022671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of thrombocytes and plasma for the regulation of hemostasis in type II diabetics].
    Sinzinger H; Fitscha P
    Vasa; 1985; 14(2):121-4. PubMed ID: 4013489
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biorheological views of diabetic macroangiopathy].
    Uchimura I
    Nihon Rinsho; 2006 Nov; 64(11):2159-63. PubMed ID: 17087312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation and thrombosis in diabetes.
    Hess K; Grant PJ
    Thromb Haemost; 2011 May; 105 Suppl 1():S43-54. PubMed ID: 21479339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.